Status:
RECRUITING
Hybrid Score to Predict OTVA-SOO in Patients with Wide Basal QRS
Lead Sponsor:
Centro Medico Teknon
Collaborating Sponsors:
Hospital Universitario Puerta del Mar
Vrije Universiteit Brussel
Conditions:
ECG
Ventricular Arrhythmias
Eligibility:
All Genders
18+ years
Brief Summary
Outflow tract ventricular arrhythmia (OTVA) is the most common type of ventricular arrhythmia, and catheter ablation (CA) is the primary treatment option for patients experiencing symptoms. Accurately...
Eligibility Criteria
Inclusion
- ventricular arrhythmia with a morphology indicating an outflow tract origin and a wide basal QRS complex
- a QRS width greater than 110 ms was considered wide
- willing and capable of providing written informed consent to the study
Exclusion
- catether ablation procedure was unsuccessful
- infrequent arrhythmia requiring ablation guided by pacemapping.
Key Trial Info
Start Date :
January 4 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 23 2024
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06602635
Start Date
January 4 2022
End Date
October 23 2024
Last Update
September 24 2024
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Vrije Universiteit Brussel
Brussels, Belgium, Belgium, 1090
2
Maria Cecilia Hospital
Cotignola, Italy, Italy, 48033
3
Niguarda Ca Granda Hospital
Milan, Italy, Italy, 20132
4
Cisanello University Hospital (Pisa, Italy)
Pisa, Italy, Italy, 56124